Retrospective and multicenter analysis of efficacy and safety of ruxolitinib in 176 Turkish patients with myelofibrosis: updated data

Simple item page
dc.contributor.authorSoyer, N
dc.contributor.authorAli, R
dc.contributor.authorTurgut, M
dc.contributor.authorHaznedaroglu, I
dc.contributor.authorYilmaz, F
dc.contributor.authorAydogdu, I
dc.contributor.authorPir, A
dc.contributor.authorKarakus, V
dc.contributor.authorOzgur, G
dc.contributor.authorKis, C
dc.contributor.authorCeran, F
dc.contributor.authorIlhan, G
dc.contributor.authorOzkan, M
dc.contributor.authorArslaner, M
dc.contributor.authorInce, I
dc.date.accessioned2025-04-10T10:37:24Z
dc.date.available2025-04-10T10:37:24Z
dc.identifier.e-issn1873-5835
dc.identifier.issn0145-2126
dc.identifier.urihttp://hdl.handle.net/20.500.14701/43006
dc.language.isoEnglish
dc.titleRetrospective and multicenter analysis of efficacy and safety of ruxolitinib in 176 Turkish patients with myelofibrosis: updated data
dc.typeMeeting Abstract

Files

Collections

Web of Science Koleksiyonu